Guifeng Lin
Active 2020–2024
- 15
- Papers
- 1,027
- Citations
- 13
- h-index
- 13
- i10-index
Self-citations are included in these numbers.
Citations per year
Citations
- 1 year (1 citations) is not shown (dated before this author's first paper)
Citation sources
Countries
This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.
Institutions
- Sichuan University20.6%
- Chinese Academy of Sciences18.6%
- Texas A&M University7.8%
- Shanghai Institute of Materia Medica7.5%
- Zhejiang University5.4%
- Peking University4.8%
- Other35.2%
Fields
- Biochemistry, Genetics and Molecular Biology31.9%
- Medicine30.3%
- Computer Science26.4%
- Chemistry3.7%
- Immunology and Microbiology2.2%
- Pharmacology, Toxicology and Pharmaceutics2.2%
- Other3.3%
Topics
- Computational Drug Discovery Methods27.1%
- SARS-CoV-2 and COVID-19 Research23.5%
- Synthesis and biological activity7.1%
- COVID-19 Clinical Research Studies5.5%
- Receptor Mechanisms and Signaling5.2%
- Inflammasome and immune disorders4.8%
- Other26.8%
Frequent coauthors
All papers
Loading papers…
